Exchange: NASDAQ·Updated 07:30 PM EDT
RNAC logo

RNAC Selecta Biosciences Inc

$9.60
$0.37
(3.71%)
Today
Closed $9.60
$0.00
(0.00%)
After Hours
Reported EarningsAug 6
Mkt Cap$290.45M
Vol65,555.00

About RNAC

Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company was founded on December 10, 2007 is headquartered in Frederick, MD.
47

Neutral Sentiment

How do you feel about RNAC?

Advertisement|Remove ads.